GB1556567A - Pharmaceutical compositions having an action on the central nervous system - Google Patents
Pharmaceutical compositions having an action on the central nervous systemInfo
- Publication number
- GB1556567A GB1556567A GB30355/77A GB3035577A GB1556567A GB 1556567 A GB1556567 A GB 1556567A GB 30355/77 A GB30355/77 A GB 30355/77A GB 3035577 A GB3035577 A GB 3035577A GB 1556567 A GB1556567 A GB 1556567A
- Authority
- GB
- United Kingdom
- Prior art keywords
- action
- pharmaceutical compositions
- nervous system
- central nervous
- central
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 210000003169 central nervous system Anatomy 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7622045A FR2358881A1 (fr) | 1976-07-20 | 1976-07-20 | Composition pharmaceutique active sur le systeme nerveux central |
| FR7719390A FR2453643A2 (fr) | 1977-06-24 | 1977-06-24 | Compositions pharmaceutiques actives sur le systeme nerveux central |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1556567A true GB1556567A (en) | 1979-11-28 |
Family
ID=26219550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB30355/77A Expired GB1556567A (en) | 1976-07-20 | 1977-07-19 | Pharmaceutical compositions having an action on the central nervous system |
Country Status (11)
-
1977
- 1977-07-18 IL IL52550A patent/IL52550A/xx unknown
- 1977-07-18 NZ NZ184666A patent/NZ184666A/xx unknown
- 1977-07-19 AU AU27151/77A patent/AU508753B2/en not_active Expired
- 1977-07-19 DE DE19772732614 patent/DE2732614A1/de not_active Withdrawn
- 1977-07-19 IE IE1509/77A patent/IE45454B1/en unknown
- 1977-07-19 SE SE7708349A patent/SE7708349L/ not_active Application Discontinuation
- 1977-07-19 GB GB30355/77A patent/GB1556567A/en not_active Expired
- 1977-07-19 LU LU77796A patent/LU77796A1/xx unknown
- 1977-07-19 CA CA283,049A patent/CA1077846A/en not_active Expired
- 1977-07-20 NL NL7708055A patent/NL7708055A/xx not_active Application Discontinuation
- 1977-07-20 JP JP8785277A patent/JPS5326327A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IE45454L (en) | 1978-01-20 |
| SE7708349L (sv) | 1978-01-21 |
| LU77796A1 (enrdf_load_html_response) | 1977-10-25 |
| DE2732614A1 (de) | 1978-01-26 |
| CA1077846A (en) | 1980-05-20 |
| IE45454B1 (en) | 1982-08-25 |
| NL7708055A (nl) | 1978-01-24 |
| IL52550A (en) | 1981-03-31 |
| AU508753B2 (en) | 1980-04-03 |
| NZ184666A (en) | 1980-04-28 |
| JPS5326327A (en) | 1978-03-11 |
| IL52550A0 (en) | 1977-10-31 |
| AU2715177A (en) | 1979-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA771090B (en) | Pharmaceutical compositions | |
| ZA774920B (en) | Pharmaceutical compositions | |
| JPS52125619A (en) | Pharmaceutical vehicle | |
| PT66622A (en) | Pharmaceutical compositions | |
| AU3111677A (en) | Pharmaceutical compositions | |
| NZ186147A (en) | Sterolin pharmaceutical compositions | |
| NZ184539A (en) | 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine pharmaceutical compositions | |
| GB1520958A (en) | 11-deoxy-16-aryl - 17,18,19,20 - tetranorprostaglandins | |
| AU2609277A (en) | Pharmaceutical compositions | |
| GB1532697A (en) | 2,3-dihydroergolines | |
| AU1214076A (en) | 2,3-dihalogen-alkanoyl-ureas | |
| PH14168A (en) | 2,4-pyrrolidinediones | |
| GB1557694A (en) | 2,9 dichlorquinacridone | |
| HK69380A (en) | Pharmaceutical compositions | |
| PT66509B (en) | Pharmaceutical compositions | |
| AU2574877A (en) | Pharmaceutical compositions | |
| GB1483330A (en) | 2,5-dimethoxy-4-chloroaniline | |
| NZ182127A (en) | 6 ,17 -dihydroxy-1 -loweralkoxycarbonyl-3-oxo-17 -pregn-4-ene-21-carboxylic acid -lactones | |
| GB1554021A (en) | 4,5-didehydroprostaglandins | |
| ZA774376B (en) | Pharmaceutical compositions having an action on the central nervous system | |
| PH13909A (en) | 17(-acetylenic-androstenes,the pharmaceutical composition | |
| HK3984A (en) | Pharmaceutical compositions | |
| ZA766301B (en) | Substituted 2,1,3-benzothiadiazine | |
| GB1554925A (en) | 2,3-methyl-eneprostaglandins | |
| GB1556567A (en) | Pharmaceutical compositions having an action on the central nervous system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |